Susquehanna International Group, LLP Nurix Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 20,472 shares of NRIX stock, worth $405,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,472

Previous 57,191 64.2%

Holding current value

$405,959

Previous $1.19 Million 61.53%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.93 - $25.69 $695,090 - $943,311	-36,719 Reduced 64.2%	20,472 $459,000
Q2 2024 Aug 15, 2024	BUY	$12.02 - $21.3 $80,077 - $141,900	6,662 Added 13.18%	57,191 $1.19 Million
Q1 2024 May 07, 2024	SELL	$7.77 - $15.66 $171,025 - $344,692	-22,011 Reduced 30.34%	50,529 $742,000
Q4 2023 Feb 14, 2024	BUY	$4.25 - $10.71 $62,976 - $158,700	14,818 Added 25.67%	72,540 $748,000
Q3 2023 Nov 14, 2023	SELL	$7.86 - $10.08 $260,629 - $334,242	-33,159 Reduced 36.49%	57,722 $453,000
Q2 2023 Aug 11, 2023	BUY	$8.7 - $13.28 $202,901 - $309,716	23,322 Added 34.52%	90,881 $907,000
Q1 2023 May 16, 2023	BUY	$8.56 - $13.26 $366,308 - $567,435	42,793 Added 172.79%	67,559 $599,000
Q4 2022 Feb 14, 2023	SELL	$9.86 - $14.59 $240,455 - $355,806	-24,387 Reduced 49.61%	24,766 $271,000
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $411,550 - $661,218	33,378 Added 211.59%	49,153 $640,000
Q2 2022 Aug 15, 2022	SELL	$7.88 - $14.82 $160,657 - $302,150	-20,388 Reduced 56.38%	15,775 $200,000
Q1 2022 May 16, 2022	SELL	$12.94 - $29.65 $74,417 - $170,517	-5,751 Reduced 13.72%	36,163 $507,000
Q4 2021 Feb 14, 2022	BUY	$26.43 - $34.5 $267,022 - $348,553	10,103 Added 31.76%	41,914 $1.21 Million
Q3 2021 Nov 15, 2021	BUY	$22.71 - $36.69 $104,375 - $168,627	4,596 Added 16.89%	31,811 $953,000
Q2 2021 Aug 11, 2021	SELL	$24.21 - $35.89 $719,109 - $1.07 Million	-29,703 Reduced 52.19%	27,215 $722,000
Q1 2021 May 17, 2021	BUY	$26.98 - $50.17 $1.54 Million - $2.86 Million	56,918 New	56,918 $1.77 Million

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $935M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Nurix Therapeutics, Inc. Transaction History